NCT07341490Recruiting
CT-Angiography Versus Angiogram as Ancillary Tests in the Determination of Death by Neurologic Criteria
A Comparison of Computed Tomography-Angiography Versus Four-vessel Angiography in the Determination of Brain Death
Source: ClinicalTrials.gov · Last updated 17 Mar 2026
Brief summary (registry, in English)
Diagnostic performance of a novel protocol for computed tomography-angiography, as ancillary test in the determination of complete cerebral infarction, in comparison to four vessel angiography.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 50 (estimated)
- First submitted
- 21 Dec 2025
- Start date
- 1 Jan 2026
- Primary completion date
- 31 Dec 2028
- Lead sponsor
- Region Stockholm
- Diseases
- Stroke
- NCT number
- NCT07341490
What you commit to
- Study type: Observational
- Planned participants: 50
- From 1 Jan 2026 to the primary completion date, 31 Dec 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Treatment with extracorporeal membrane oxygenation (ECMO)
Other
- Radiologic examination by computed tomography deemed too challenging due to respiratory or circulatory instability, as determined by responsible clinician
Who the study is looking for
- Adults 18 years or older
- Ongoing critical care due to severe acute brain injury
- Four vessel angiography necessary for the determination of complete cerebral infarction, according to Swedish legislation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karolinska University Hospital Coordinator of this site? Confirm its status | Stockholm | Sweden | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.